Digestive System Diseases: Clinical Trials

483 trials for Digestive System Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

151 completed, 106 unknown, 73 recruiting, 43 terminated. 483 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 1483Completed 151, Unknown 106, Recruiting 73, Terminated 43, Not yet recruiting 38, Active not recruiting 30, Withdrawn 29, Enrolling by invitation 9, Suspended 4

Follow Digestive System Diseases: new trials by email Literature Review of Digestive System Diseases trials Research Report on Digestive System Diseases

Trials (filtered) newest first · largest first

All 483 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pilot Trial of Xylitol for C. Difficile De-Colonization in Patients With Inflammatory Bowel Disease
Xylitol - Inflammatory Bowel Disease (IBD), Clostridioides Difficile Infection
Early Phase 1Not yet recruitingBrigham and Women's Hospital692027-03-012026-11-16
NK521 in the Treatment of Advanced Solid Tumors
NK521 Cell Injection - Hepatocellular Carcinoma (HCC), Ovarian Cancer
Early Phase 1Not yet recruitingBase Therapeutics (Shanghai) Co., Ltd.182027-01-012026-09-30
Oral Aeromonas sp. MTB Phage Therapy for Pouchitis in Patients With Ulcerative Colitis (UC)
MTB-targeted phage therapy - Pouchitis, UC - Ulcerative Colitis
Early Phase 1Not yet recruitingJinling Hospital, China122027-01-012026-10-22
Immune Checkpoint Inhibitor (ICI)-Drug-Drug Interaction (DDI) Study
ICI Therapy - Gastrointestinal Neoplasms, Genitourinary Cancer
Early Phase 1Not yet recruitingIndiana University802027-01-012026-11-18
GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer
GLP1-RA (semaglutide) - Pancreatic Cancer, Colorectal Cancer
Early Phase 1RecruitingUniversity of Arizona302026-10-072026-11-16
Silymarin Versus N-Acetylcysteine as Protective Effect Against Anti-tuberculosis Drugs Induced Liver Injury.
Antituberculosis drugs Group - Drug-Induced Acute Liver Injury, Tuberculosis (TB)
Early Phase 1Not yet recruitingAssiut University1022026-10-012026-10-21
Clinical Study of CBG131 CAR-T Cell Injection for the Treatment of CLDN18.2-Positive Advanced Gastric and Pancreatic Cancer
CBG131 CAR-T Cell Infusion - Advanced Gastric and Pancreatic Cancer
Early Phase 1Not yet recruitingFirst Affiliated Hospital of Wenzhou Medical University182026-09-302026-02-06
THIO and Cadonilimab in Resectable Hepatocellular Carcinoma
ateganosine, Cadonilimab - Resectable Hepatocellular Carcinoma
Early Phase 1RecruitingUniversity of Texas Southwestern Medical Center602026-09-012026-09-03
Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer
[64Cu]CM500, [68Ga]CM500, PET/MR - Bladder Cancer, Glioma
Early Phase 1Not yet recruitingLumina Pharmaceuticals Inc402026-09-012026-08-28
VIBRANT-IBD: Brain Effects of Non-Invasive Vagus Nerve Stimulation in IBD Remission
Non-invasive vagus nerve stimulation (nVNS) - Inflammatory Bowel Diseases (IBD), Remission of IBD
Early Phase 1Enrolling by invitationUniversity of Gdansk152026-08-072026-08-11
Psilocybin-Assisted Psychotherapy in Treating Irritable Bowel Syndrome (IBS)
Psilocybin 25 mg, Psychotherapy Treatment Session, Niacin 100 mg - IBS - Irritable Bowel Syndrome
Early Phase 1Not yet recruitingNYU Langone Health102026-08-012026-03-05
ND-12 Combined With H-6 for Adult Chronic Inflammatory Diarrhea
mesalazine, ND-12, ND-12/H-6 - Diarrhea Chronic, UC - Ulcerative Colitis
Early Phase 1RecruitingThe Second Hospital of Nanjing Medical University362026-07-202026-08-17
Safety and Feasibility of CIK Cell Therapy in HCC After Tumor Resection
Autologous Cytokine-Induced Killer (CIK) Cells - Hepatocellular Carcinoma (HCC)
Early Phase 1Not yet recruitingRoyan Institute62026-07-012026-07-16
Evaluation of [⁶⁸Ga/¹⁷⁷Lu]HT547: Safety, Biodistribution, and Dosimetry in Solid Tumors
[⁶⁸Ga]Ga-HT547 and [¹⁷⁷Lu]Lu-HT547 - Breast Cancer, Head and Neck Cancer (H&N)
Early Phase 1Not yet recruitingHua Pang202026-06-012026-06-10
Fecal Microbiota Transplantation for the Treatment of Refractory Hepatic Encephalopathy After TIPS Surgery
Fecal Microbiota Transplantation, Rifaximin、Lactulose, Dietary Fiber Prebiotic - Hepatic Encephalopathy, Fecal Microbiota Transplantation
Early Phase 1RecruitingAir Force Military Medical University, China262026-06-012026-07-06
A Study to Evaluate the Human Biodistribution and Dosimetry of the Radionuclide Labeled IR199 in Patients With Gastric Cancer and Pancreatic Cancer
[68Ga]/ [131I]-IR199 - Gastric Cancer, Pancreatic Cancer
Early Phase 1RecruitingHuashan Hospital102026-06-012026-07-16
A Study of Dose Escalation of ES502 in Patients With Advanced Pancreatic Cancer
ES502 Injection - Pancreatic Cancer
Early Phase 1RecruitingRuijin Hospital242026-05-182026-06-16
Botensilimab, Balstilimab, and SBRT in Colorectal Cancer
Stereotactic Body Radiation Therapy (SBRT), Botensilimab, Balstilimab - Non-MSI-H or pMMR Colorectal Cancer With Liver Metastasis
Early Phase 1RecruitingMassachusetts General Hospital152026-05-122026-05-13
5G Remote Robotic Surgery for Hepatic Echinococcosis in High-Altitude Region
5G-based Telerobotic Hepatectomy - Hepatic Echinococcosis
Early Phase 1Not yet recruitingWest China Hospital102026-05-012026-04-24
A Preliminary Efficacy of SNA028 in Patients With Advanced Colorectal Cancer Positive for GPA33
GPA33-CC;177Lu-SmartD2 - Colorectal Cancer
Early Phase 1Not yet recruitingSmartNuclide Biopharma202026-05-012026-05-15

Showing 20 of 483. Sign in to see all of them.

Narrower conditions

Pancreatic Neoplasms (81)  ·  Colorectal Neoplasms (56)  ·  Carcinoma, Hepatocellular (53)  ·  Stomach Neoplasms (36)  ·  Colonic Neoplasms (26)  ·  Breast Neoplasms (25)  ·  Crohn Disease (20)  ·  Colitis, Ulcerative (19)  ·  Lung Neoplasms (17)  ·  Non-alcoholic Fatty Liver Disease (15)  ·  Ovarian Neoplasms (15)  ·  Cystic Fibrosis (14)  ·  Inflammatory Bowel Diseases (13)  ·  Liver Neoplasms (13)  ·  Rectal Neoplasms (12)

Broader conditions

Neoplasms (261)  ·  Neoplasms by Site (260)  ·  Digestive System Neoplasms (257)  ·  Gastrointestinal Diseases (251)  ·  Intestinal Diseases (165)  ·  Liver Diseases (128)  ·  Gastrointestinal Neoplasms (123)  ·  Colonic Diseases (113)  ·  Pancreatic Diseases (113)  ·  Endocrine System Diseases (98)  ·  Endocrine Gland Neoplasms (94)  ·  Neoplasms by Histologic Type (92)  ·  Intestinal Neoplasms (88)  ·  Neoplasms, Glandular and Epithelial (83)

Interventions

Magnetic Resonance Spectroscopy (13)  ·  Fluorouracil (8)  ·  Oxaliplatin (8)  ·  Biopsy (6)  ·  Fecal Microbiota Transplantation (6)  ·  Gemcitabine (6)  ·  Irinotecan (6)  ·  Leucovorin (6)  ·  Bevacizumab (5)  ·  Nivolumab (5)  ·  Omeprazole (5)  ·  Radiosurgery (5)  ·  Blood Specimen Collection (4)  ·  Capecitabine (4)  ·  Cisplatin (4)

Sponsors

Mayo Clinic (14)  ·  Peking Union Medical College Hospital (9)  ·  Cedars-Sinai Medical Center (6)  ·  Massachusetts General Hospital (6)  ·  Ruijin Hospital (6)  ·  Assiut University (5)  ·  Beijing Ditan Hospital (5)  ·  Case Comprehensive Cancer Center (5)  ·  OHSU Knight Cancer Institute (5)  ·  Shanghai Changzheng Hospital (5)  ·  Shanghai Yunying Medical Technology (5)  ·  Stanford University (5)  ·  BioSyngen Pte Ltd (4)  ·  H. Lee Moffitt Cancer Center and Research Institute (4)  ·  Jonsson Comprehensive Cancer Center (4)

Countries

United States (207)  ·  China (141)  ·  Egypt (11)  ·  Canada (8)  ·  France (7)  ·  United Kingdom (6)  ·  Netherlands (5)  ·  Sweden (5)  ·  Pakistan (4)  ·  Turkey (Türkiye) (4)  ·  Italy (3)  ·  Spain (3)  ·  Taiwan (3)  ·  Belgium (2)  ·  Denmark (2)

Top investigators

Mingyu Sun, doctor (3)  ·  Alexander Guimaraes (2)  ·  Baiyong Shen (2)  ·  Charles D Lopez (2)  ·  Christopher P Cardozo, MD (2)  ·  David Katzka, MD (2)  ·  Jennifer Goralski, MD (2)  ·  Mingyong Han, PhD (2)  ·  Scott Irwin, MD, PhD (2)  ·  Stephen Pandol, MD (2)  ·  Wei-Fen Xie, M.D. (2)  ·  Yuqing Li, PhD (2)  ·  Zhaohui Zhu (2)  ·  Aaron J Scott, MD (1)  ·  Aaron Weitzman, MD (1)

Results publications

PMID 10786614, PMID 10898704, PMID 11773501, PMID 12167685, PMID 12220494, PMID 12677098, PMID 12739326, PMID 12851164, PMID 15958805, PMID 17197840, PMID 17255260, PMID 17262812, PMID 17416034, PMID 17499606, PMID 17635375, PMID 17701250, PMID 18338782, PMID 18639230, PMID 19057395, PMID 19095497, PMID 19109835, PMID 20016696, PMID 20335583, PMID 20423763, PMID 20518581, PMID 20980771, PMID 21047794, PMID 21157444, PMID 21618351, PMID 21654383, PMID 22298568, PMID 22321518, PMID 22370735, PMID 22415019, PMID 22454486, PMID 22735166, PMID 22892368, PMID 22941427, PMID 23340005, PMID 23453547, PMID 23993913, PMID 24398454, PMID 24493717, PMID 24603562, PMID 24614108, PMID 24696183, PMID 25027973, PMID 25060964, PMID 25209657, PMID 25309092

NIH funding

P30CA033572 (2), P30CA068485 (2), 1UG3DK136705-01 (1), 2023 (1), 2025 (1), K01DK120742 (1), P30CA006973 (1), P30CA014089 (1), P30CA043703 (1), P30CA046934 (1), P30CA060553 (1), P30CA072720 (1), P30CA093373 (1), P30CA124435 (1), P30CA138292 (1)